ZURA

Zura Bio Ltd

May 15 • 04:00PM ET

4.72

-0.11 -2.28 %

Healthcare • Biotechnology • USA • Small • NASD

Index	-	P/E	-	EPS (ttm)	-1.22	Insider Own	28.85%	Shs Outstand	94.88M	Perf Week	-1.46%
Market Cap	448.39M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	7.87%	Shs Float	67.59M	Perf Month	-17.34%
Enterprise Value	222.80M	PEG	-	EPS next Q	-0.18	Inst Own	54.88%	Short Float	10.32%	Perf Quarter	-22.37%
Income	-106.13M	P/S	-	EPS this Y	26.53%	Inst Trans	4.22%	Short Ratio	11.29	Perf Half Y	1.94%
Sales	0.00M	P/B	2.06	EPS next Y	11.40%	ROA	-52.92%	Short Interest	6.97M	Perf YTD	-9.92%
Book/sh	2.29	P/C	1.99	EPS next 5Y	6.55%	ROE	-59.78%	52W High	7.44 -36.56%	Perf Year	293.33%
Cash/sh	2.37	P/FCF	-	EPS past 3/5Y	80.48% -	ROIC	-48.93%	52W Low	0.98 381.63%	Perf 3Y	-14.18%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.10% 7.13%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-60.98%	Oper. Margin	-	ATR (14)	0.35	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	19.33	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	37.16	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	19.33	EPS Q/Q	-15.09%	SMA20	-7.30%	Beta	0.07	Target Price	16.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-16.47%	Rel Volume	0.85	Prev Close	4.83
Employees	40	LT Debt/Eq	0.00	Earnings	May 07 BMO	SMA200	7.58%	Avg Volume	617.87K	Price	4.72
IPO	Sep 03, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-26.58% -	Trades		Volume	525,104	Change	-2.28%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-09-26	Initiated	Wedbush	Outperform	$15
Nov-04-24	Initiated	Leerink Partners	Outperform	$15
Sep-05-24	Initiated	H.C. Wainwright	Neutral	$5
May-03-24	Initiated	Piper Sandler	Overweight	$26
Oct-10-23	Initiated	Ladenburg Thalmann	Buy	$10
Aug-25-23	Initiated	Oppenheimer	Outperform	$17
Jun-22-23	Initiated	Guggenheim	Buy	$20
Jun-14-23	Initiated	Chardan Capital Markets	Buy	$14
May-24-23	Initiated	Raymond James	Strong Buy	$20

May-14-26 07:30AM	Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-13-26 07:30AM	Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer (Business Wire)
May-07-26 07:30AM	Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates (Business Wire) -7.16%
May-04-26 04:05PM	Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-19-26 04:05PM	Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates (Business Wire) -10.13%
09:31PM	Loading…
Mar-06-26 09:31PM	UniFirst, Elastic NV, and More Stocks See Action From Activist Investors (Barrons.com)
Mar-05-26 06:30AM	Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress (Business Wire)
Mar-02-26 06:30AM	Zura Bio to Participate in Upcoming Investor Conferences (Business Wire)
Feb-27-26 06:30AM	Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (Business Wire)
Feb-25-26 06:30AM	Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants (Business Wire)
Feb-24-26 04:01PM	Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants (Business Wire)
Feb-23-26 06:30AM	Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors (Business Wire) +5.32%
Feb-16-26 06:03AM	Zura Bio Highlights Key Phase 2 Tibulizumab Readouts at Guggenheim Biotech Summit 2026 (MarketBeat)
Feb-04-26 06:30AM	Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit (Business Wire)
Jan-21-26 08:50AM	Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer (Business Wire) +26.15%
06:30AM	Loading…
Jan-12-26 06:30AM	Zura Bio Reports Business Updates and Outlook for 2026 (Business Wire)
Nov-29-25 01:26AM	Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress (Insider Monkey)
Nov-13-25 06:30AM	Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates (Business Wire) -9.72%
Aug-20-25 06:30AM	Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference (Business Wire)
Aug-14-25 08:15AM	Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates (Business Wire) +8.18%
Jul-17-25 04:30PM	Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +51.94%
Jul-01-25 06:30AM	Zura Bio Announces Chief Financial Officer Transition (Business Wire)
May-27-25 06:30AM	Zura Bio to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-20-25 06:30AM	Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa (Business Wire)
May-08-25 06:30AM	Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates (Business Wire)
Mar-25-25 06:30AM	Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates (Business Wire) +10.37%
Feb-24-25 06:30AM	Zura Bio to Present at the Leerink Partners Global Healthcare Conference (Business Wire)
Dec-23-24 06:30AM	Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis (Business Wire)
Nov-25-24 06:30AM	Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference (Business Wire) +12.09%
Nov-14-24 04:30PM	Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis (Business Wire) -17.81% -12.22%
06:30AM	Loading…
Nov-07-24 06:30AM	Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates (Business Wire)
Oct-30-24 06:30AM	Zura Bio to Participate in Two Upcoming Investor Conferences in November (Business Wire)
Sep-03-24 06:00AM	Zura Bio to Present at Three Upcoming Investor Conferences in September (Business Wire)
Aug-13-24 09:21AM	Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights (Business Wire)
Aug-12-24 04:05PM	Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants (Business Wire)
Aug-09-24 04:05PM	Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants (Business Wire)
Aug-01-24 08:00AM	Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors (GlobeNewswire)
Jul-12-24 06:10AM	Zura Bio Commences Warrant Exchange Offer and Consent Solicitation (Business Wire) -6.08%
06:08AM	The 3 Most Undervalued Biotech Stocks to Buy in July 2024 (InvestorPlace)
Jun-14-24 06:00AM	Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024 (Business Wire)
Jun-06-24 06:00AM	Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology (Business Wire) -8.11%
Jun-03-24 06:00AM	Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024 (Business Wire) -7.05%
May-31-24 09:55AM	Wall Street Analysts Predict a 235.2% Upside in Zura Bio Limited (ZURA): Here's What You Should Know (Zacks)
May-29-24 06:00AM	Zura Bio Announces Participation in June Investor Conferences (Business Wire)
May-24-24 06:18AM	3 Penny Stocks to Buy Now: May 2024 (InvestorPlace)
May-15-24 09:55AM	How Much Upside is Left in Zura Bio Limited (ZURA)? Wall Street Analysts Think 248.84% (Zacks)
May-14-24 12:00PM	Zura Bio Limited (ZURA) Upgraded to Buy: Here's What You Should Know (Zacks) +7.72%
May-12-24 03:26PM	13 Penny Stocks with Insider Buying in 2024 (Insider Monkey)
May-10-24 03:14PM	Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments (GuruFocus.com)
May-09-24 01:56PM	ZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024 (InvestorPlace)
06:00AM	Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights (Business Wire)
Apr-25-24 02:18AM	Director Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA) (GuruFocus.com) +9.37%
Apr-18-24 09:22AM	Zura Bio Announces Oversubscribed $112.5 Million Private Placement (Business Wire) +17.89%
Apr-08-24 06:00AM	Zura Bio Announces Robert Lisicki as CEO and Director (Business Wire)
Mar-28-24 11:54AM	ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023 (InvestorPlace) +10.78%
06:00AM	Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer (Business Wire)
Mar-04-24 06:00AM	Zura Bio Announces Participation at March Conferences (Business Wire)
Feb-02-24 06:00AM	Zura Bio Announces Participation at February Investor Conferences (Business Wire) +6.11%
Jan-08-24 06:00AM	Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO (Business Wire)
Jan-03-24 06:00AM	Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit (Business Wire)
Dec-04-23 06:00AM	Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok (Business Wire)
Nov-14-23 06:00AM	Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors (Business Wire) +10.00%
Nov-13-23 06:30AM	Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights (Business Wire) -6.54%
Sep-12-23 05:00AM	Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute (Business Wire)
Sep-05-23 08:55PM	Oppenheimer Says These 2 Stocks Could Double Your Money Heres Why They Could Jump (TipRanks)
Aug-25-23 09:42AM	Netflix upgraded, Olaplex downgraded: Wall Street's top analyst calls (The Fly)
Aug-14-23 07:00AM	Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights (Business Wire)
Jun-23-23 06:30AM	Zura Bio to Join the Russell 2000® and Russell 3000® Indexes (Business Wire) -5.69%
Jun-06-23 06:34AM	Daily Vickers Top Buyers & Sellers for 06/06/2023 (Argus Research) +16.80%
04:00AM	Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist (Business Wire)
Jun-01-23 10:20AM	Load Up, Says Raymond James About These 2 Strong Buy Stocks (TipRanks) +10.82%
Apr-27-23 07:39AM	Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases (Business Wire)
Apr-14-23 05:00AM	Zura Bio Announces Appointment of Chief Scientific Officer (Business Wire)
Mar-27-23 09:35AM	Zura Bio Limited Announces Share Redemptions and Lock-up Agreement (Business Wire) -42.76%
Mar-21-23 06:13AM	Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp (Business Wire) -11.27%

Zura Bio Ltd. is a clinical-stage biotechnology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.

Co-FounderDr. Sandeep C. Kulkarni M.D.

Co-Founder & DirectorDr. Someit Sidhu M.D.

Ph.D.Dr. Kiran Nistala MBBS

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AI Biotechnology LLC	10% Owner	Feb 26 '26	Buy	6.25	2,000,000	12,500,000	6,552,725	Mar 02 05:55 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ZURA

Zura Bio Ltd

Upgrade your Finviz experience